NCT07333768

Brief Summary

The goal of this experimental study is to test the feasibility and validity of a new orthosis in patients with ankle lesions (external popliteal sciatic nerve or nerve injuries resulting in loss of ankle dorsiflexion) of both sexes and all ages. The main question it aims to answer is:Is the new orthosis a support for ankle stability??Does the new orthosis improve ankle function and patients' quality of life??The control group will be the subjects themselves when wearing their conventional ankle orthosis or without it. Participants must wear the new ankle orthosis for at least one month to assess the effectiveness of the orthosis and evaluate any changes that have occurred in the ankle joint and muscles.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
6mo left

Started Jul 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 8, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 12, 2026

Completed
6 months until next milestone

Study Start

First participant enrolled

July 1, 2026

Expected
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2026

2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

April 28, 2026

Status Verified

December 1, 2025

Enrollment Period

4 months

First QC Date

December 8, 2025

Last Update Submit

April 27, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Device Feasibility

    Device feasibility will be assessed through participants' awareness of the device, as an indicator of its accessibility, visibility, and potential for effective implementation within the target population. A self diary Will be requested

    Baseline and up to 4 weeks

Secondary Outcomes (3)

  • Ankle function with virtual reality

    Baseline and up to 4 weeks

  • Range of motion with Gyko device

    Baseline and up to 4 weeks

  • Footprint with a pressure platform

    Baseline and up to 4 weeks

Study Arms (2)

EQUISOCK group

EXPERIMENTAL

Participants must wear the new ankle orthosis during assessments and in their daily lives for at least one month, which is the duration of the study.

Device: EQUISOCK

Other ankle orthosis

ACTIVE COMPARATOR

Participants must wear the conventional ankle orthosis (and without orthosis) during assessments and in their daily lives, before wear the new one.

Device: Other ankle orthosis

Interventions

Participants must wear the conventional ankle orthosis and without orthosis, during assessments and before wearing the new one

Other ankle orthosis
EQUISOCKDEVICE

Participants must wear the new ankle orthosis during assessments and in their daily lives for at least one month, which is the duration of the study.

EQUISOCK group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • patients with chronic ankle injuries
  • patients with external popliteal sciatic nerve lesion or nerve injuries resulting in loss of ankle dorsiflexion
  • patients who have already been prescribed an orthosis
  • patients of all ages

You may not qualify if:

  • inability to stand actively and stably
  • inability to walk unaided
  • inability to follow instructions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Salamanca

Salamanca, Salamanca, 37007, Spain

Location

Central Study Contacts

Rocio Llamas-Ramos Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
DEVICE FEASIBILITY
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 8, 2025

First Posted

January 12, 2026

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

October 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

April 28, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations